» Articles » PMID: 11265809

The Effects of a Serotoninergic Substrate of the Nucleus Accumbens on Latent Inhibition

Overview
Publisher Springer
Date 2001 Mar 27
PMID 11265809
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Latent inhibition is an effect consisting of a delay in the acquisition of a stimulus in response to quenching of its significance by repeated presentation (pre-exposure) before combination with the reinforcement. This phenomenon is used for studies of the mechanisms of attention. Experiments were performed on rats to determine whether latent inhibition could be formed in a passive avoidance response in conditions of blockade of serotoninergic terminals in the nucleus accumbens. After pre-exposure, sham-operated animals demonstrated a delay in acquisition of the stimulus as compared with animals not subjected to pre-exposure. Bilateral injection of the neurotoxin 5,7-dihydroxytryptamine into the nucleus accumbens led to disruption of latent inhibition, which could in turn be prevented by systemic administration of haloperidol before training. The importance of serotoninergic terminals in the nucleus accumbens for latent inhibition is discussed, along with the mechanism of their interaction with the dopaminergic system during the formation of this effect.

Citing Articles

Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Xu S, Gullapalli R, Frost D Schizophr Res. 2014; 161(2-3):452-7.

PMID: 25487700 PMC: 4308953. DOI: 10.1016/j.schres.2014.10.034.


Paradoxical effects of low dose MDMA on latent inhibition in the rat.

Nelson A, Thur K, Marsden C, Cassaday H Neuropharmacology. 2012; 67:331-6.

PMID: 23201353 PMC: 3574236. DOI: 10.1016/j.neuropharm.2012.11.012.


Reduced activity at the 5-HT(2C) receptor enhances reversal learning by decreasing the influence of previously non-rewarded associations.

Nilsson S, Ripley T, Somerville E, Clifton P Psychopharmacology (Berl). 2012; 224(2):241-54.

PMID: 22644128 DOI: 10.1007/s00213-012-2746-5.


Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Nelson A, Thur K, Marsden C, Cassaday H Int J Neuropsychopharmacol. 2011; 15(4):485-96.

PMID: 21557885 PMC: 3325501. DOI: 10.1017/S1461145711000599.


The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Weiner I Psychopharmacology (Berl). 2003; 169(3-4):257-97.

PMID: 12601500 DOI: 10.1007/s00213-002-1313-x.

References
1.
Lubow R, Gewirtz J . Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull. 1995; 117(1):87-103. DOI: 10.1037/0033-2909.117.1.87. View

2.
Conrad L, Leonard C, Pfaff D . Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study. J Comp Neurol. 1974; 156(2):179-205. DOI: 10.1002/cne.901560205. View

3.
Gray N, Pilowsky L, Gray J, Kerwin R . Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res. 1995; 17(1):95-107. DOI: 10.1016/0920-9964(95)00034-j. View

4.
Loskutova L, Lukyanenko FYa , Ilyuchenok RYu . Interaction of serotonin- and dopaminergic systems of the brain in mechanisms of latent inhibition in rats. Neurosci Behav Physiol. 1990; 20(6):500-5. DOI: 10.1007/BF01237275. View

5.
Bardo M, Neisewander J, Pierce R . Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs. Pharmacol Biochem Behav. 1989; 32(3):683-9. DOI: 10.1016/0091-3057(89)90018-x. View